• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Neutrophil-lymphocyte ratio in the immune checkpoint inhibitors-related atherosclerosis.

作者信息

Zhang Nan, Tse Gary, Liu Tong

机构信息

Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.

出版信息

Eur Heart J. 2021 Jun 7;42(22):2215. doi: 10.1093/eurheartj/ehab158.

DOI:10.1093/eurheartj/ehab158
PMID:33748846
Abstract
摘要

相似文献

1
Neutrophil-lymphocyte ratio in the immune checkpoint inhibitors-related atherosclerosis.免疫检查点抑制剂相关动脉粥样硬化中的中性粒细胞与淋巴细胞比值
Eur Heart J. 2021 Jun 7;42(22):2215. doi: 10.1093/eurheartj/ehab158.
2
Predictive value of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in non-small cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis.中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值对免疫检查点抑制剂治疗非小细胞肺癌患者的预测价值：一项荟萃分析。
Int Immunopharmacol. 2020 Aug;85:106677. doi: 10.1016/j.intimp.2020.106677. Epub 2020 Jun 9.
3
Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors.预处理中性粒细胞与淋巴细胞比值和突变负担作为免疫检查点抑制剂肿瘤反应的生物标志物。
Nat Commun. 2021 Feb 1;12(1):729. doi: 10.1038/s41467-021-20935-9.
4
Prognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio in Outcome of Immune Checkpoint Inhibitors.基线中性粒细胞与淋巴细胞比值对免疫检查点抑制剂治疗结果的预后价值
Cancer Invest. 2019;37(6):265-274. doi: 10.1080/07357907.2019.1639057. Epub 2019 Jul 15.
5
Peripheral Blood Markers Identify Risk of Immune-Related Toxicity in Advanced Non-Small Cell Lung Cancer Treated with Immune-Checkpoint Inhibitors.外周血标志物可识别免疫检查点抑制剂治疗晚期非小细胞肺癌相关免疫毒性的风险。
Oncologist. 2019 Aug;24(8):1128-1136. doi: 10.1634/theoncologist.2018-0563. Epub 2019 Apr 23.
6
Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab.基线中性粒细胞与淋巴细胞比值（NLR）及其衍生的 NLR 可预测接受纳武利尤单抗治疗的晚期黑色素瘤患者的总生存期。
J Immunother Cancer. 2018 Jul 16;6(1):74. doi: 10.1186/s40425-018-0383-1.
7
The Impact of Radiation Therapy on Lymphocyte Count and Survival in Metastatic Cancer Patients Receiving PD-1 Immune Checkpoint Inhibitors.放射治疗对接受 PD-1 免疫检查点抑制剂治疗的转移性癌症患者淋巴细胞计数和生存的影响。
Int J Radiat Oncol Biol Phys. 2019 Jan 1;103(1):142-151. doi: 10.1016/j.ijrobp.2018.09.010. Epub 2018 Sep 15.
8
Predictive value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in advanced hepatocellular carcinoma patients treated with anti-PD-1 therapy.中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值对接受抗 PD-1 治疗的晚期肝细胞癌患者的预测价值。
Cancer Med. 2020 Jul;9(14):4962-4970. doi: 10.1002/cam4.3135. Epub 2020 May 18.
9
[Neutrophil/lymphocyte ratio in complete blood count as a mortality predictor in breast cancer].[全血细胞计数中的中性粒细胞/淋巴细胞比值作为乳腺癌死亡率的预测指标]
Rev Med Chil. 2016 Jun;144(6):691-6. doi: 10.4067/S0034-98872016000600001.
10
Investigation of the correlation between some immune system and biochemical indicators in patients with type 2 diabetes.2型糖尿病患者某些免疫系统指标与生化指标之间的相关性研究。
Hum Antibodies. 2016 Jun 8;24(1-2):25-31. doi: 10.3233/HAB-150290.

引用本文的文献

1
Cardiovascular and venous thromboembolism risks in cancer patients treated with immune checkpoint inhibitors compared to non-users- a multi-center retrospective study.与未使用免疫检查点抑制剂的癌症患者相比，使用免疫检查点抑制剂治疗的癌症患者发生心血管和静脉血栓栓塞的风险——一项多中心回顾性研究。
Cardiooncology. 2024 Sep 7;10(1):59. doi: 10.1186/s40959-024-00264-8.
2
Prognostic value of cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis: A systematic review and meta-analysis.心血管磁共振成像在免疫检查点抑制剂相关心肌炎中的预后价值：一项系统评价与荟萃分析
Cancer Innov. 2024 Apr 15;3(3):e109. doi: 10.1002/cai2.109. eCollection 2024 Jun.
3
Predictive role of systemic immune-inflammation index and neutrophil/lymphocyte ratio values in infants with retinopathy of prematurity.
全身免疫炎症指数和中性粒细胞/淋巴细胞比值对早产儿视网膜病变的预测作用。
Graefes Arch Clin Exp Ophthalmol. 2024 Oct;262(10):3125-3134. doi: 10.1007/s00417-024-06493-y. Epub 2024 Apr 24.
4
Early detection of immune checkpoint inhibitor-related subclinical cardiotoxicity: A pilot study by using speckle tracking imaging and three-dimensional echocardiography.免疫检查点抑制剂相关亚临床心脏毒性的早期检测：一项使用斑点追踪成像和三维超声心动图的初步研究。
Front Cardiovasc Med. 2022 Dec 21;9:1087287. doi: 10.3389/fcvm.2022.1087287. eCollection 2022.
5
Relationship Between Monocyte-to-Lymphocyte Ratio as Well as Other Leukocyte-Derived Ratios and Carotid Plaques in Patients with Coronary Heart Disease: A RCSCD-TCM Study.冠心病患者单核细胞与淋巴细胞比值及其他白细胞衍生比值与颈动脉斑块的关系：一项基于RCSCD-TCM的研究
J Inflamm Res. 2022 Sep 7;15:5141-5156. doi: 10.2147/JIR.S375759. eCollection 2022.
6
Adverse Cardiovascular Complications following prescription of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) inhibitors: a propensity-score matched Cohort Study with competing risk analysis.程序性细胞死亡蛋白1（PD-1）和程序性细胞死亡配体1（PD-L1）抑制剂处方后的不良心血管并发症：一项倾向评分匹配的队列研究及竞争风险分析
Cardiooncology. 2022 Mar 17;8(1):5. doi: 10.1186/s40959-021-00128-5.